2020
DOI: 10.1016/j.ando.2020.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Management of thyroid dysfunctions in the elderly. French Endocrine Society consensus statement 2019. Long version

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
17
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4
2
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(19 citation statements)
references
References 128 publications
2
17
0
Order By: Relevance
“…The trend of FT4 concentrations in older population was consistent with previous studies which also demonstrated little change of FT4 concentrations with aging [26]. This stability despite aging may be due to a combination of reduced T4 synthesis and secretion by the thyroid cells and reduced metabolic thyroxine clearance [5]. Increasing in TSH with aging was observed based on this population.…”
Section: Discussionsupporting
confidence: 90%
See 3 more Smart Citations
“…The trend of FT4 concentrations in older population was consistent with previous studies which also demonstrated little change of FT4 concentrations with aging [26]. This stability despite aging may be due to a combination of reduced T4 synthesis and secretion by the thyroid cells and reduced metabolic thyroxine clearance [5]. Increasing in TSH with aging was observed based on this population.…”
Section: Discussionsupporting
confidence: 90%
“…We investigated a rapid decrease in FT3 with aging in the older population. This may be due to reduced activity of 5'mono-deiodase, which catalyzes deiodination of T4 into T3, or/and reduced stimulation by TSH with aging [5]. The trend of FT4 concentrations in older population was consistent with previous studies which also demonstrated little change of FT4 concentrations with aging [26].…”
Section: Discussionsupporting
confidence: 87%
See 2 more Smart Citations
“…The bulk data suggest that overall QoL is good in LT4-treated patients with hypothyroidism-even when symptoms are present (or persist)-but do not explain why a few percent of biochemically corrected patients complain of poor QoL. A few studies (such as those by Mooijaart et al [ 88 ] and Recker et al [ 89 ]) focused on older patients with SCH, in whom the definition of hypothyroidism differs [ 106 ]; we suggest that the assessment of other well-defined patient populations might facilitate the identification of risk factors for poor QoL.…”
Section: Discussionmentioning
confidence: 99%